Fig. 1

Scenario analyses: potential total savings of SQ Tree SLIT-tablets vs. Tree Pollen SCIT. Potential total savings according to total costs. Total cost of three-year’s treatment are discounted with 1.5% as described in methods, except for the scenario analyses “0% discount rate” and “3% discount rate” where the parameter discount rate was changed to 0 or 3%, respectively. SQ Tree SLIT standardized quality birch pollen sublingual immunotherapy, Tree Pollen SCIT Tree Pollen subcutaneous immunotherapy